BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

CNS Pharmaceuticals Inc. – Material Contracts

NASDAQ: CNSP    
Share price (11/13/26): $2.89    
Market cap (11/13/26): $4.224 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 12 pages CNS Pharmaceuticals, Inc. 2020 Equity Plan
12/34/56
EX-10.4
from 10-Q 13 pages Indemnity Agreement
12/34/56
EX-10.3
from 10-Q 6 pages May 13, 2026 by Email Christopher Downs Re: Separation From CNS Pharmaceuticals, Inc
12/34/56
EX-10.2
from 8-K 23 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 37 pages Securities Purchase Agreement
12/34/56
EX-10.19
from 10-K 9 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 6 pages February 27, 2026 by Email Sandra Silberman [***] [***] Re: Separation From CNS Pharmaceuticals, Inc
12/34/56
EX-10.1
from 8-K 8 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 8 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 8 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 6 pages December 16, 2025 by Email John Climaco [***] Re: Separation From CNS Pharmaceuticals, Inc
12/34/56
EX-10.1
from 8-K 7 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 12 pages CNS Pharmaceuticals, Inc. 2020 Equity Plan
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.27
from S-1 34 pages Securities Purchase Agreement
12/34/56
EX-10.27
from DRS 34 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 21 pages Stock Purchase Agreement Between Cns Pharmaceuticals, Inc., and Cortice Biosciences, Inc., Dated: July 29, 2024
12/34/56
EX-10.1
from 8-K 33 pages Exclusive License Agreement for Tpi-287 Between Cortice Biosciences, Inc. and Cns Pharmaceuticals, Inc
12/34/56
EX-10.1
from 8-K 3 pages Waiver and Consent Agreement
12/34/56